An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension

The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.

Inclusion Criteria:

• Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
• Both eyes having best corrected visual acuity better than 20/50

Exclusion Criteria:

• Advanced glaucoma
• Closed or barely open anterior chamber or history of angle closure